2021 April

ASCO and ESMO Abstracts
ESMO and ASCO Abstracts 2020
ESMO Abstracts: CheckMate 067 Results at ESMO 2020 Abstract No : Abstract: #1105P Indication : Melanoma Intervention : Nivolumab Company : Bristol-Myers Squibb Technology...
ASCO and ESMO Abstracts
ASCO and ESMO Abstracts 2020
ASCO Abstracts ASCO: Lisocabtagene maraleucel (liso-cel) Abstract No : 8040 Indication : Non-Hodgkin's Lymphoma (aggressive) Intervention : Lisocabtagene maraleucel Company : Juno Therapeutics, a Bristol-Myers...